www.fdanews.com/articles/198064-willow-labs-settles-false-advertising-claims-for-22-million
Willow Labs Settles False Advertising Claims for $22 Million
July 15, 2020
Willow Labs and its marketers will stop making claims that its light therapy device, the Willow Curve, treats chronic, severe pain and associated inflammation, under a $22 million settlement with the Federal Trade Commission (FTC).
The FTC alleged that the marketers promoted the device nationwide as a “smart” device that is “clinically proven,” even though they lacked scientific evidence to support the claims.
They also falsely claimed that Willow Curve, a curved device that emits infrared and invisible light, was approved by the FDA to diagnose and treat chronic, severe pain and reduce inflammation, according to the FTC.